[{"AccountsPayableCurrent_0_Q1_USD":4506000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_1_Q1_USD":19300000.0,"MarketableSecuritiesNoncurrent_0_Q1_USD":8533000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q1_USD":8533000.0,"RepaymentsOfDebtAndCapitalLeaseObligations_1_Q1_USD":5000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":159000.0,"InvestmentIncomeInterest_1_Q1_USD":1208000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q1_USD":479000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-23913000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":509716000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":201000.0,"OtherAssetsNoncurrent_0_Q1_USD":6814000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q1_USD":70700000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":130000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":29000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":159000.0,"IncreaseDecreaseInOtherOperatingAssets_1_Q1_USD":1602000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":6082000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":1266000.0,"AmortizationOfFinancingCosts_1_Q1_USD":9000.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_1_Q1_USD":0.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":479000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":1692000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":1383000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":448000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_1_Q1_USD":228000.0,"DebtSecuritiesAvailableForSaleRealizedGainLoss_1_Q1_USD":0.0,"ShareBasedCompensation_1_Q1_USD":6082000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_0_Q1_USD":0.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q1_USD":226596000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q1_USD":430400000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q1_USD":195404000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":6082000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":125000.0,"MarketableSecuritiesCurrent_0_Q1_USD":195404000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":288000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_1_Q1_USD":14659000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":20170000.0,"PreferredStockValue_0_Q1_USD":null,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"LiabilitiesCurrent_0_Q1_USD":13834000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":443042000.0,"Liabilities_0_Q1_USD":115355000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":133000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":1887000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":5553000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.54,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":99788000.0,"Depreciation_1_Q1_USD":120000.0,"CommonStockSharesOutstanding_0_Q1_shares":44452701.0,"CommonStockSharesIssued_0_Q1_shares":44452701.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":226456000.0,"AssetsCurrent_0_Q1_USD":424807000.0,"Assets_0_Q1_USD":443042000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":6880073.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":489000.0,"CommonStockValue_0_Q1_USD":5000.0,"PaymentsToAcquireMarketableSecurities_1_Q1_USD":86317000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-67197000.0,"NetIncomeLoss_1_Q1_USD":-24392000.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PreferredStockSharesAuthorized_0_Q1_shares":10000000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"OperatingIncomeLoss_1_Q1_USD":-25723000.0,"OperatingExpenses_1_Q1_USD":25723000.0,"InterestExpense_1_Q1_USD":7000.0,"CommonStockSharesAuthorized_0_Q1_shares":490000000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-17932000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"AccruedLiabilitiesCurrent_0_Q1_USD":8880000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":44824587.0,"StockholdersEquity_0_Q1_USD":327687000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-182523000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":1056000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":2947000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":180000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"RestrictedCashNoncurrent_0_Q1_USD":140000.0,"Ticker":"KOD","CIK":"1468748","name":"KODIAK SCIENCES INC.","OfficialName":"Kodiak Sciences Inc Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"350038530.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200511"}]